Results 71 to 80 of about 25,351 (211)
Background There is little data on Trichomonas vaginalis infection in Ghana. This study evaluated the prevalence of trichomoniasis using different diagnostic methods and determined the risk factors for infection in patients.
Richard Harry Asmah+7 more
doaj +1 more source
Review of anti-Trichomonas vaginalis herbs and their therapeutic effects [PDF]
Introduction and Objectives: Trichomonas vaginitis is the most common non-viral disease transmitted through sexual contact. Metronidazole is the most effective medication that has the same adverse effects as other synthetic drugs.
Fatemeh Zahra Karimi+3 more
doaj +1 more source
This study investigated the prevalence and diversity of Matryoshka RNA viruses (MaRNAV) in wild birds in the San Francisco Bay Area, California. Using RNA sequencing and RT‐PCR, we identified two novel MaRNAVs (MaRNAV‐5 and ‐6) associated with haemosporidian infections in passerines and raptors. These findings suggest a high prevalence of these viruses,
Carlos W. Esperanza+3 more
wiley +1 more source
Urogenital pathogens, associated with Trichomonas vaginalis, among pregnant women in Kilifi, Kenya : a nested case-control study [PDF]
Background: Screening of curable sexually transmitted infections is frequently oriented towards the diagnosis of chlamydia, gonorrhea, syphilis and trichomoniasis, whereas other pathogens, sometimes associated with similar urogenital syndromes, remain ...
Cools, Piet+5 more
core +4 more sources
Abstract Introduction Pre‐exposure prophylaxis (PrEP) services are linked to increased sexually transmitted infection (STI) diagnoses, which may facilitate PrEP uptake. We hypothesized that point‐of‐care (POC) STI testing and treatment would improve PrEP initiation and persistence. Methods Between September 2023 and November 2024, we conducted a single‐
Dvora Joseph Davey+8 more
wiley +1 more source
LAMP assay for point‐of‐care tests. ABSTRACT Sexually transmitted infections (STIs) remain a significant public health concern. Given the asymptomatic nature of many STIs, diagnostic testing is critical for determining the appropriate treatment, enabling effective tracing and reducing the risk of further transmission.
Yasaman Ahmadi+4 more
wiley +1 more source
Local join therapy of vaginal infections by nifuratel-nistatin [PDF]
A test included 40 women in the reproductive age with clinical symptoms of vaginitis and microbiologycal examination. They were treated by combined therapy of vaginal tablets of nifuratel, 500mg and nistatin 200 000 i. u.
Amra Habibović,+7 more
doaj
Abstract Introduction Sexually transmitted infections (STIs) in pregnancy contribute to poor perinatal outcomes and increased HIV acquisition risk, underscoring the importance of delivering STI/HIV services within antenatal care. Few studies evaluate women's perspectives on the co‐delivery of antenatal STI testing and HIV pre‐exposure prophylaxis (PrEP)
Jerusha N. Mogaka+14 more
wiley +1 more source
2024 European guidelines for the management of genital herpes
Genital herpes—guidelines for diagnostic and treatment (2024): strategies for diagnosis, management and follow‐up of the most common sexually transmitted infection. The guidelines covers common clinical scenarios (including recurrent genital herpes), infection during pregnancy and coinfection with human immunodeficiency virus.
Rajul Patel+10 more
wiley +1 more source